MedTrace Logo

PPI Test in GP Patients

NCT00318084 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2007-08-17

No results posted yet for this study

Summary

The purpose of this study is to determine the diagnostic value of two week treatment with Nexium as a confirmatory test for patients with suspected reflux disease.

Conditions

  • GERD

Interventions

DRUG

Esomeprazole

PROCEDURE

Ambulatory 24-hour esophageal pH-monitoring

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER

  • AstraZeneca

    lead INDUSTRY

Principal Investigators

  • AstraZeneca Netherlands Medical Director · AstraZeneca

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00318084 on ClinicalTrials.gov